Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

551 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Efficacy of ApTOLL in Patients With Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial.
Hernández-Jiménez M, Abad-Santos F, Cotgreave I, Gallego J, Jilma B, Flores A, Jovin TG, Vivancos J, Hernández-Pérez M, Molina CA, Montaner J, Casariego J, Dalsgaard M, Liebeskind DS, Cobo E, Castellanos M, Portela PC, Masjuán J, Moniche F, Tembl JI, Terceño Izaga M, Arenillas JF, Callejas P, Olivot JM, Calviere L, Henon H, Mazighi M, Piñeiro D, Pugliese M, González VM, Moro MA, Garcia-Tornel A, Lizasoain I, Ribo M. Hernández-Jiménez M, et al. Among authors: jilma b. JAMA Neurol. 2023 Aug 1;80(8):779-788. doi: 10.1001/jamaneurol.2023.1660. JAMA Neurol. 2023. PMID: 37338893 Clinical Trial.
APRIL: A double-blind, placebo-controlled, randomized, Phase Ib/IIa clinical study of ApTOLL for the treatment of acute ischemic stroke.
Hernández-Jiménez M, Abad-Santos F, Cotgreave I, Gallego J, Jilma B, Flores A, Jovin TG, Vivancos J, Molina CA, Montaner J, Casariego J, Dalsgaard M, Hernández-Pérez M, Liebeskind DS, Cobo E, Ribo M. Hernández-Jiménez M, et al. Among authors: jilma b. Front Neurol. 2023 Feb 24;14:1127585. doi: 10.3389/fneur.2023.1127585. eCollection 2023. Front Neurol. 2023. PMID: 36908619 Free PMC article.
Drug-Drug Interactions in Patients with Acute Respiratory Distress Syndrome.
Bischof T, Schaller C, Buchtele N, Staudinger T, Ullrich R, Kraft F, Andersson ML, Jilma B, Schoergenhofer C. Bischof T, et al. Among authors: jilma b. Pharmaceutics. 2024 Feb 21;16(3):303. doi: 10.3390/pharmaceutics16030303. Pharmaceutics. 2024. PMID: 38543197 Free PMC article.
Differential regulation of human thrombospondin-1 upon systemic desmopressin versus endotoxin challenge.
Scheuba A, Zagrapan B, Martelanz L, Eder V, Ibrahim N, Bleichert S, Knöbl V, Hayden H, von Kuenheim S, Münch K, Buchtele N, Schoergenhofer C, Kovacevic KD, Lackner E, Drucker C, Neumayer C, Jilma B, Brostjan C. Scheuba A, et al. Among authors: jilma b. Thromb Res. 2024 May;237:205-208. doi: 10.1016/j.thromres.2024.01.011. Epub 2024 Jan 15. Thromb Res. 2024. PMID: 38521738 Free article. No abstract available.
Add-on erythropoietin in autoimmune hemolytic anemia.
Moser MM, Jilma B. Moser MM, et al. Among authors: jilma b. Blood Adv. 2024 Mar 12;8(5):1320-1321. doi: 10.1182/bloodadvances.2023012297. Blood Adv. 2024. PMID: 38470435 Free PMC article. No abstract available.
A randomized, double-blind study on the safety and immunogenicity of rTSST-1 variant vaccine: phase 2 results.
Schoergenhofer C, Gelbenegger G, Hasanacevic D, Schöner L, Steiner MM, Firbas C, Buchtele N, Derhaschnig U, Tanzmann A, Model N, Larcher-Senn J, Drost M, Eibl MM, Roetzer A, Jilma B. Schoergenhofer C, et al. Among authors: jilma b. EClinicalMedicine. 2024 Jan 5;67:102404. doi: 10.1016/j.eclinm.2023.102404. eCollection 2024 Jan. EClinicalMedicine. 2024. PMID: 38274114 Free PMC article.
551 results